Sonnet Biotherapeutics Holdings: Post Purchase Agreement, Co Has Right From Time to Time at Option to Sell to Chardan up to Lesser of $25 Mln
Sonnet Biotherapeutics Holdings:在收購協議後,該公司有權不時選擇向Chardan出售不超過2500萬美元以內的較低金額
Sonnet Biotherapeutics Holdings: Post Purchase Agreement, Co Has Right From Time to Time at Option to Sell to Chardan up to Lesser of $25 Mln
Sonnet Biotherapeutics Holdings:在收購協議後,該公司有權不時選擇向Chardan出售不超過2500萬美元以內的較低金額
使用瀏覽器的分享功能,分享給你的好友吧